1. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018) Authors: Wells, Philip S.; Lensing, Anthonie W. A.; Haskell, Lloyd; Levitan, Bennett; Laliberté, François; Durkin, Michael; Ashton, Veronica; Xiao, Yongling; Crivera, Concetta; Lejeune, Dominique; Schein, Jeff; Lefebvre, Patrick Journal: Journal of medical economics Issue: Volume 21:Number 6(2018) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism. (27th March 2022) Authors: Bistervels, Ingrid M.; Bavalia, Roisin; Gebel, Martin; Lensing, Anthonie W. A.; Middeldorp, Saskia; Prins, Martin H.; Coppens, Michiel Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 6(2022) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin. Issue 2 (17th February 2021) Authors: Boonyawat, Kochawan; Lensing, Anthonie W. A.; Prins, Martin H.; Beyer‐Westendorf, Jan; Prandoni, Paolo; Martinelli, Ida; Middeldorp, Saskia; Pap, Akos F.; Weitz, Jeffrey I.; Crowther, Mark Journal: Research and practice in thrombosis and haemostasis Issue: Volume 5:Issue 2(2021) Page Start: 308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis. (22nd August 2021) Authors: Khan, Faizan; Tritschler, Tobias; Kimpton, Miriam; Wells, Philip S.; Kearon, Clive; Weitz, Jeffrey I.; Büller, Harry R.; Raskob, Gary E.; Ageno, Walter; Couturaud, Francis; Prandoni, Paolo; Palareti, Gualtiero; Legnani, Cristina; Kyrle, Paul A.; Eichinger, Sabine; Eischer, Lisbeth; Becattini, Cec... Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 11(2021) Page Start: 2801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. (23rd June 2021) Authors: Willmann, Stefan; Marostica, Eleonora; Snelder, Nelleke; Solms, Alexander; Jensen, Markus; Lobmeyer, Maximilian; Lensing, Anthonie W. A.; Bethune, Claudette; Morgan, Erin; Yu, Rosie Z.; Wang, Yanfeng; Jung, Shiangtung W.; Geary, Richard; Bhanot, Sanjay Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 8(2021) Page Start: 890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically‐based pharmacokinetic predictions. (23rd August 2021) Authors: Willmann, Stefan; Coboeken, Katrin; Zhang, Yang; Mayer, Hannah; Ince, Ibrahim; Mesic, Emir; Thelen, Kirstin; Kubitza, Dagmar; Lensing, Anthonie W. A.; Yang, Haitao; Zhu, Peijuan; Mück, Wolfgang; Drenth, Henk‐Jan; Lippert, Jörg Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 10(2021) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation. (4th June 2020) Authors: Young, Guy; Lensing, Anthonie W. A.; Monagle, Paul; Male, Christoph; Thelen, Kirstin; Willmann, Stefan; Palumbo, Joseph S.; Kumar, Riten; Nurmeev, Ildar; Hege, Kerry; Bajolle, Fanny; Connor, Philip; Hooimeijer, Hélène L.; Torres, Marcela; Chan, Anthony K. C.; Kenet, Gili; Holzhauer, Susanne; Sant... Journal: Journal of thrombosis and haemostasis Issue: Volume 18:Number 7(2020) Page Start: 1672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study. (12th May 2021) Authors: Wiegers, Hanke M. G.; van Es, Josien; Pap, Ákos F.; Lensing, Anthonie W. A.; Middeldorp, Saskia; Scheres, Luuk J. J. Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 7(2021) Page Start: 1759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study. (25th February 2015) Authors: Fermann, Gregory J.; Erkens, Petra M. G.; Prins, Martin H.; Wells, Philip S.; Pap, Ákos F.; Lensing, Anthonie W. A.; Kline, Jeffrey Journal: Academic emergency medicine Issue: Volume 22:Number 3(2015:Mar.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study. (25th February 2015) Authors: Fermann, Gregory J.; Erkens, Petra M. G.; Prins, Martin H.; Wells, Philip S.; Pap, Ákos F.; Lensing, Anthonie W. A.; Kline, Jeffrey Journal: Academic emergency medicine Issue: Volume 22:Number 3(2015:Mar.) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗